La telemedicina como herramienta de control clínico de la Diabetes Mellitus Tipo 2 en Latinoamérica

Abstract

Background: Telemedicine uses technology to provide medical services in remote or underserved areas through smartphones, phone calls, and computers. In Latin America, telemedicine has gained importance, especially after the COVID-19 pandemic, by enabling medical follow-up during the health crisis. However, it is currently underutilized for managing chronic diseases such as Diabetes Mellitus type 2, despite the significant increase of this disease in the population due to lifestyle changes. General objective: This study aims to describe telemedicine as a tool that enables the clinical management of type 2 diabetes mellitus in Latin America. Methodology: A literature review was conducted based on publications from the last five years using the following databases: PubMed, ScienceDirect, Scopus, Taylor & Francis, Web of Science, and LILACS. Conclusion: Telemedicine is a tool that permits the clinical management of type 2 DM in Latin America, especially in those patients with a lack of follow-up or inadequate adherence to treatment. Studies have shown that the implementation of digital solutions, the use of teleconsultation, and telecare have improved the monitoring and control of diabetes, enabling adequate management of the disease and improving blood glucose levels in patients